Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?
Els Torreele, Yap Boum, Ismael Adjaho, Franck Guy Biaou Alé, Sal Ha Issoufou, Geza Harczi, Chibuzo Okonta, Piero Olliaro
Topics & Concepts
Ebola virusCommitBusinessIncentiveDiseaseEbolavirusDrug developmentInfectious disease (medical specialty)Public relationsMedicinePolitical scienceEconomicsDrugComputer scienceMicroeconomicsPsychiatryPathologyDatabaseViral Infections and Outbreaks ResearchSARS-CoV-2 and COVID-19 ResearchPharmaceutical Economics and Policy